{"transactions":[{"id":713635,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T23:41:51.000Z","date":"2026-07-02","kind":"grant","planned":false,"acquired":true,"shares":17746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 17,746 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":89174,"source":{"system":"sec-edgar","filing":"0001193125-26-297811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710190/000119312526297811/ownership.xml","form_type":"4"}},{"id":794264,"issuer":{"id":4780,"kind":"organization","name":"AMN HEALTHCARE SERVICES INC","symbol":"AMN"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-04T20:44:16.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":8304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units do not have an expiration date."}],"balance_after":8304,"derivative":{"underlying":"Common Stock","underlying_shares":8304},"source":{"system":"sec-edgar","filing":"0001628280-26-029887","document":"wk-form4_1777927453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142750/000162828026029887/wk-form4_1777927453.xml","form_type":"4"}},{"id":1111741,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T23:34:02.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":71428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 71,428 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":71428,"source":{"system":"sec-edgar","filing":"0000950170-25-086452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710190/000095017025086452/ownership.xml","form_type":"4"}},{"id":1228854,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T00:52:20.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":19158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests in three equal annual installments beginning March 1, 2026."}],"balance_after":19158,"derivative":{"exercise_price":305.855,"exercise_date":"2026-03-01","expiration_date":"2035-02-28","underlying":"Common Stock, $.01 Par Value","underlying_shares":19158},"source":{"system":"sec-edgar","filing":"0001225208-25-002926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520825002926/doc4.xml","form_type":"4"}},{"id":1228853,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2025-03-05T00:52:20.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":7407,"price":305.86,"value":2265505.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":66160,"source":{"system":"sec-edgar","filing":"0001225208-25-002926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520825002926/doc4.xml","form_type":"4"}},{"id":1228852,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2025-03-05T00:52:20.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2083,"price":305.86,"value":637106.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":73567,"source":{"system":"sec-edgar","filing":"0001225208-25-002926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520825002926/doc4.xml","form_type":"4"}},{"id":1228851,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2025-03-05T00:52:20.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted shares vest in three equal annual installments beginning March 1, 2026."}],"balance_after":75650,"source":{"system":"sec-edgar","filing":"0001225208-25-002926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520825002926/doc4.xml","form_type":"4"}},{"id":1228850,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2025-03-05T00:52:20.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":15982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":70255,"source":{"system":"sec-edgar","filing":"0001225208-25-002926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520825002926/doc4.xml","form_type":"4"}},{"id":1359276,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-11-19T22:24:52.000Z","date":"2024-11-15","kind":"gift","planned":false,"acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54273,"source":{"system":"sec-edgar","filing":"0001225208-24-010071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824010071/doc4.xml","form_type":"4"}},{"id":1596730,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-03-05T22:43:37.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5928,"price":333.36,"value":1976158.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":54323,"source":{"system":"sec-edgar","filing":"0001225208-24-003711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824003711/doc4.xml","form_type":"4"}},{"id":1596729,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-03-05T22:43:37.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2710,"price":333.36,"value":903405.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":60251,"source":{"system":"sec-edgar","filing":"0001225208-24-003711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824003711/doc4.xml","form_type":"4"}},{"id":1596728,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-03-05T22:43:37.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":12792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":62961,"source":{"system":"sec-edgar","filing":"0001225208-24-003711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824003711/doc4.xml","form_type":"4"}},{"id":1607221,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-02T00:44:36.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":18677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning March 1, 2025."}],"balance_after":18677,"derivative":{"exercise_price":336.475,"exercise_date":"2025-03-01","expiration_date":"2034-02-28","underlying":"Common Stock, $.01 Par Value","underlying_shares":18677},"source":{"system":"sec-edgar","filing":"0001225208-24-003418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824003418/doc4.xml","form_type":"4"}},{"id":1607220,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-03-02T00:44:36.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":5127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2025."}],"balance_after":50169,"source":{"system":"sec-edgar","filing":"0001225208-24-003418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824003418/doc4.xml","form_type":"4"}},{"id":1641048,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":0,"derivative":{"exercise_price":149.135,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, $.01 Par Value","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641047,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":5168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":905,"derivative":{"exercise_price":149.135,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, $.01 Par Value","underlying_shares":5168},"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641046,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-15","kind":"gift","planned":false,"acquired":true,"shares":312,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":1437,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641045,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-15","kind":"gift","planned":false,"acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45042,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641044,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-15","kind":"gift","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45354,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641043,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":905,"price":149.135,"value":134967.175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":45554,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641042,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-13","kind":"sale","planned":false,"acquired":false,"shares":6083,"price":340,"value":2068220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":44649,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1641041,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-15T22:30:08.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5168,"price":149.135,"value":770729.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":50732,"source":{"system":"sec-edgar","filing":"0001225208-24-002196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824002196/doc4.xml","form_type":"4"}},{"id":1646317,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-13T22:28:07.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":1017,"price":335.2568,"value":340956.1656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $335.211 to $335.29 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":45564,"source":{"system":"sec-edgar","filing":"0001225208-24-001959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001959/doc4.xml","form_type":"4"}},{"id":1656824,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-07T02:02:55.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":false,"shares":1017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2016.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":139.22,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock, $.01 Par Value","underlying_shares":1017},"source":{"system":"sec-edgar","filing":"0001225208-24-001652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001652/doc4.xml","form_type":"4"}},{"id":1656823,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-07T02:02:55.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":false,"shares":5684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2016.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":1017,"derivative":{"exercise_price":139.22,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock, $.01 Par Value","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001225208-24-001652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001652/doc4.xml","form_type":"4"}},{"id":1656822,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-07T02:02:55.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":true,"shares":1017,"price":139.22,"value":141586.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":46581,"source":{"system":"sec-edgar","filing":"0001225208-24-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001652/doc4.xml","form_type":"4"}},{"id":1656821,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-07T02:02:55.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":5684,"price":325,"value":1847300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":45564,"source":{"system":"sec-edgar","filing":"0001225208-24-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001652/doc4.xml","form_type":"4"}},{"id":1656820,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-02-07T02:02:55.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":true,"shares":5684,"price":139.22,"value":791326.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023.  In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)."}],"balance_after":51248,"source":{"system":"sec-edgar","filing":"0001225208-24-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520824001652/doc4.xml","form_type":"4"}},{"id":1898222,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-05-10T21:14:01.000Z","date":"2023-05-08","kind":"gift","planned":false,"acquired":true,"shares":390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":1125,"source":{"system":"sec-edgar","filing":"0001225208-23-005695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823005695/doc4.xml","form_type":"4"}},{"id":1898221,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-05-10T21:14:01.000Z","date":"2023-05-08","kind":"gift","planned":false,"acquired":false,"shares":390,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45564,"source":{"system":"sec-edgar","filing":"0001225208-23-005695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823005695/doc4.xml","form_type":"4"}},{"id":1973992,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-03-03T22:11:49.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":1889,"price":289.44,"value":546752.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":45954,"source":{"system":"sec-edgar","filing":"0001225208-23-003384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823003384/doc4.xml","form_type":"4"}},{"id":1987231,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-02-28T23:01:44.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":4992,"price":294.27,"value":1468995.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":47843,"source":{"system":"sec-edgar","filing":"0001225208-23-002995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823002995/doc4.xml","form_type":"4"}},{"id":1987230,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-02-28T23:01:44.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":572,"price":294.27,"value":168322.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":52835,"source":{"system":"sec-edgar","filing":"0001225208-23-002995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823002995/doc4.xml","form_type":"4"}},{"id":1987229,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-02-28T23:01:44.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":11265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":53407,"source":{"system":"sec-edgar","filing":"0001225208-23-002995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823002995/doc4.xml","form_type":"4"}},{"id":1993402,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-25T02:12:49.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning March 1, 2024."}],"balance_after":19600,"derivative":{"exercise_price":294.61,"exercise_date":"2024-03-01","expiration_date":"2033-02-22","underlying":"Common Stock, $.01 Par Value","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001225208-23-002826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823002826/doc4.xml","form_type":"4"}},{"id":1993401,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-02-25T02:12:49.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":5304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2024."}],"balance_after":42142,"source":{"system":"sec-edgar","filing":"0001225208-23-002826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520823002826/doc4.xml","form_type":"4"}},{"id":2135605,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-10-18T21:59:55.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":4000,"price":300.001,"value":1200004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2022."}],"balance_after":36838,"source":{"system":"sec-edgar","filing":"0001225208-22-011021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822011021/doc4.xml","form_type":"4"}},{"id":2209223,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-11T23:16:00.000Z","date":"2022-07-08","kind":"exercise","acquired":false,"shares":860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 25, 2015.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":120.895,"exercise_date":"2016-02-25","expiration_date":"2025-02-25","underlying":"Common Stock, $.01 Par Value","underlying_shares":860},"source":{"system":"sec-edgar","filing":"0001225208-22-008763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822008763/doc4.xml","form_type":"4"}},{"id":2209222,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-11T23:16:00.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":5557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 25, 2015.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":860,"derivative":{"exercise_price":120.895,"exercise_date":"2016-02-25","expiration_date":"2025-02-25","underlying":"Common Stock, $.01 Par Value","underlying_shares":5557},"source":{"system":"sec-edgar","filing":"0001225208-22-008763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822008763/doc4.xml","form_type":"4"}},{"id":2209221,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-07-11T23:16:00.000Z","date":"2022-07-08","kind":"exercise","acquired":true,"shares":860,"price":120.895,"value":103969.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":40838,"source":{"system":"sec-edgar","filing":"0001225208-22-008763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822008763/doc4.xml","form_type":"4"}},{"id":2209220,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-07-11T23:16:00.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":6521,"price":275,"value":1793275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":39978,"source":{"system":"sec-edgar","filing":"0001225208-22-008763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822008763/doc4.xml","form_type":"4"}},{"id":2209219,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-07-11T23:16:00.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":5557,"price":120.895,"value":671813.515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":46499,"source":{"system":"sec-edgar","filing":"0001225208-22-008763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822008763/doc4.xml","form_type":"4"}},{"id":2300379,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-08T21:35:18.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":1311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 26, 2014.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":78.035,"exercise_date":"2015-02-26","expiration_date":"2024-02-26","underlying":"Common Stock, $.01 Par Value","underlying_shares":1311},"source":{"system":"sec-edgar","filing":"0001225208-22-005739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822005739/doc4.xml","form_type":"4"}},{"id":2300378,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-08T21:35:18.000Z","date":"2022-04-06","kind":"exercise","acquired":false,"shares":6656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 26, 2014.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":1311,"derivative":{"exercise_price":78.035,"exercise_date":"2015-02-26","expiration_date":"2024-02-26","underlying":"Common Stock, $.01 Par Value","underlying_shares":6656},"source":{"system":"sec-edgar","filing":"0001225208-22-005739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822005739/doc4.xml","form_type":"4"}},{"id":2300377,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-04-08T21:35:18.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":1311,"price":78.035,"value":102303.885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":40942,"source":{"system":"sec-edgar","filing":"0001225208-22-005739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822005739/doc4.xml","form_type":"4"}},{"id":2300376,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-04-08T21:35:18.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":8126,"price":250,"value":2031500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":39631,"source":{"system":"sec-edgar","filing":"0001225208-22-005739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822005739/doc4.xml","form_type":"4"}},{"id":2300375,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-04-08T21:35:18.000Z","date":"2022-04-06","kind":"exercise","acquired":true,"shares":6656,"price":78.035,"value":519400.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022."}],"balance_after":47757,"source":{"system":"sec-edgar","filing":"0001225208-22-005739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822005739/doc4.xml","form_type":"4"}},{"id":2354884,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-03T22:28:29.000Z","date":"2022-03-03","kind":"gift","acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":735,"source":{"system":"sec-edgar","filing":"0001225208-22-004166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822004166/doc4.xml","form_type":"4"}},{"id":2354883,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-03T22:28:29.000Z","date":"2022-03-03","kind":"gift","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41101,"source":{"system":"sec-edgar","filing":"0001225208-22-004166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822004166/doc4.xml","form_type":"4"}},{"id":2354882,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-03T22:28:29.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":932,"price":236.48,"value":220399.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":41501,"source":{"system":"sec-edgar","filing":"0001225208-22-004166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822004166/doc4.xml","form_type":"4"}},{"id":2365626,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-02T01:18:50.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":2363,"price":229.62,"value":542592.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":42433,"source":{"system":"sec-edgar","filing":"0001225208-22-003753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003753/doc4.xml","form_type":"4"}},{"id":2365625,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-02T01:18:50.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":1119,"price":229.64,"value":256967.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":44796,"source":{"system":"sec-edgar","filing":"0001225208-22-003753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003753/doc4.xml","form_type":"4"}},{"id":2365624,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-03-02T01:18:50.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":5352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":45915,"source":{"system":"sec-edgar","filing":"0001225208-22-003753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003753/doc4.xml","form_type":"4"}},{"id":2372216,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-26T01:49:26.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":27778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning March 1, 2023."}],"balance_after":27778,"derivative":{"exercise_price":227.02,"exercise_date":"2023-03-01","expiration_date":"2032-02-23","underlying":"Common Stock, $.01 Par Value","underlying_shares":27778},"source":{"system":"sec-edgar","filing":"0001225208-22-003488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003488/doc4.xml","form_type":"4"}},{"id":2372215,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-02-26T01:49:26.000Z","date":"2021-05-18","kind":"gift","acquired":true,"shares":335,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":335,"source":{"system":"sec-edgar","filing":"0001225208-22-003488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003488/doc4.xml","form_type":"4"}},{"id":2372214,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-02-26T01:49:26.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":6195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2023."}],"balance_after":40563,"source":{"system":"sec-edgar","filing":"0001225208-22-003488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003488/doc4.xml","form_type":"4"}},{"id":2372213,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & CEO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-02-26T01:49:26.000Z","date":"2021-05-18","kind":"gift","acquired":false,"shares":335,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34368,"source":{"system":"sec-edgar","filing":"0001225208-22-003488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520822003488/doc4.xml","form_type":"4"}},{"id":2820732,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & COO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:28:26.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":2465,"price":210.31,"value":518414.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":34703,"source":{"system":"sec-edgar","filing":"0001225208-21-004368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004368/doc4.xml","form_type":"4"}},{"id":2820731,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & COO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:28:26.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":1122,"price":210.31,"value":235967.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":37168,"source":{"system":"sec-edgar","filing":"0001225208-21-004368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004368/doc4.xml","form_type":"4"}},{"id":2820730,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & COO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:28:26.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":5701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":38290,"source":{"system":"sec-edgar","filing":"0001225208-21-004368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004368/doc4.xml","form_type":"4"}},{"id":2829902,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & COO, Evernorth"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-27T01:22:33.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":28773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning March 1, 2022."}],"balance_after":28773,"derivative":{"exercise_price":213.8,"exercise_date":"2022-03-01","expiration_date":"2031-02-24","underlying":"Common Stock, $.01 Par Value","underlying_shares":28773},"source":{"system":"sec-edgar","filing":"0001225208-21-003977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003977/doc4.xml","form_type":"4"}},{"id":2829901,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"President & COO, Evernorth"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-02-27T01:22:33.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":6034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2022."}],"balance_after":32589,"source":{"system":"sec-edgar","filing":"0001225208-21-003977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003977/doc4.xml","form_type":"4"}},{"id":3031462,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-09-15T22:34:50.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":1000,"price":168.768,"value":168768.0,"ownership":{"direct":true},"balance_after":26555,"source":{"system":"sec-edgar","filing":"0001225208-20-011598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820011598/doc4.xml","form_type":"4"}},{"id":3238443,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:03.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":2653,"price":179.41,"value":475974.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":25555,"source":{"system":"sec-edgar","filing":"0001225208-20-003958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003958/doc4.xml","form_type":"4"}},{"id":3238442,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:03.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":6940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":28208,"source":{"system":"sec-edgar","filing":"0001225208-20-003958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003958/doc4.xml","form_type":"4"}},{"id":3238441,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:03.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":548,"price":185.76,"value":101796.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":21268,"source":{"system":"sec-edgar","filing":"0001225208-20-003958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003958/doc4.xml","form_type":"4"}},{"id":3241412,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-29T02:27:24.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":20016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning February 26, 2021."}],"balance_after":20016,"derivative":{"exercise_price":192.02,"exercise_date":"2021-02-26","expiration_date":"2030-02-26","underlying":"Common Stock, $.01 Par Value","underlying_shares":20016},"source":{"system":"sec-edgar","filing":"0001225208-20-003813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003813/doc4.xml","form_type":"4"}},{"id":3241411,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-02-29T02:27:24.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":5469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vests in three equal annual installments beginning February 26, 2021."}],"balance_after":21816,"source":{"system":"sec-edgar","filing":"0001225208-20-003813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003813/doc4.xml","form_type":"4"}},{"id":3613291,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:24:29.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":646,"price":177.85,"value":114891.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":16347,"source":{"system":"sec-edgar","filing":"0001225208-19-004750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004750/doc4.xml","form_type":"4"}},{"id":3613290,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:24:29.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2016-2018 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":16993,"source":{"system":"sec-edgar","filing":"0001225208-19-004750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004750/doc4.xml","form_type":"4"}},{"id":3623467,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:22:21.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in three equal annual installments beginning February 27, 2020."}],"balance_after":18125,"derivative":{"exercise_price":183.4405,"exercise_date":"2020-02-27","expiration_date":"2029-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001225208-19-004243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004243/doc4.xml","form_type":"4"}},{"id":3623466,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:22:21.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":5247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning February 27, 2020."}],"balance_after":14925,"source":{"system":"sec-edgar","filing":"0001225208-19-004243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004243/doc4.xml","form_type":"4"}},{"id":3656947,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Phantom Stock Units","published_at":"2019-02-14T22:32:24.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":780.7241,"price":185.12,"value":144527.645392,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock represents the right to receive the cash value of one share of Cigna Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of phantom stock are payable in cash in accordance with the terms of Cigna's Deferred Compensation Plan.  The reporting person may transfer his phantom stock account into an alternative investment account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of phantom stock are payable in cash in accordance with the terms of Cigna's Deferred Compensation Plan.  The reporting person may transfer his phantom stock account into an alternative investment account."}],"balance_after":780.7241,"derivative":{"exercise_price":0,"underlying":"Common Stock, $.01 Par Value","underlying_shares":780.7241},"source":{"system":"sec-edgar","filing":"0001225208-19-002560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819002560/doc4.xml","form_type":"4"}},{"id":3719279,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":17530,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms."}],"balance_after":17530,"derivative":{"exercise_price":197.35,"expiration_date":"2028-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":17530},"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719278,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6073,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":6073,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719277,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6701,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019."}],"balance_after":6701,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6701},"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719276,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":6417,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6417},"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719275,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":7967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":7967,"derivative":{"exercise_price":78.035,"expiration_date":"2024-02-26","underlying":"Common Stock, $0.01 Par Value","underlying_shares":7967},"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719274,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":39.0592,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse's 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."}],"balance_after":39.0592,"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719273,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":232.5516,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."}],"balance_after":232.5516,"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719272,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:21:57.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":9678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":9678,"source":{"system":"sec-edgar","filing":"0001567619-18-008714","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008714/doc1.xml","form_type":"4"}},{"id":3719203,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":17530,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms."}],"balance_after":17530,"derivative":{"exercise_price":197.35,"expiration_date":"2028-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":17530},"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719202,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6073,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":6073,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719201,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6701,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019."}],"balance_after":6701,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6701},"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719200,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":6417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":6417,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $0.01 Par Value","underlying_shares":6417},"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719199,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":7967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":7967,"derivative":{"exercise_price":78.035,"expiration_date":"2024-02-26","underlying":"Common Stock, $0.01 Par Value","underlying_shares":7967},"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719198,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":39.0592,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse's 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."}],"balance_after":39.0592,"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719197,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":232.5516,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger."}],"balance_after":232.5516,"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3719196,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:15:07.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":9678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":9678,"source":{"system":"sec-edgar","filing":"0001567619-18-008700","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008700/doc1.xml","form_type":"4"}},{"id":3720354,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":17530,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms."}],"balance_after":0,"derivative":{"exercise_price":197.35,"expiration_date":"2028-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":17530},"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720353,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6073,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720352,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6701,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $.25 Par Value","underlying_shares":6701},"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720351,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $.25 Par Value","underlying_shares":6417},"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720350,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":7967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":78.035,"expiration_date":"2024-02-26","underlying":"Common Stock, $.25 Par Value","underlying_shares":7967},"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720349,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":39.0592,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse's 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and disposed of in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720348,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":232.5516,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and disposed of in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3720347,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-12-26T18:44:30.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":9678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-008655","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008655/doc1.xml","form_type":"4"}},{"id":3855994,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-08-02T17:28:24.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":2828,"price":177.61,"value":502281.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2018."}],"balance_after":9678,"source":{"system":"sec-edgar","filing":"0001225208-18-012206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818012206/doc4.xml","form_type":"4"}},{"id":4012924,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-03-06T18:41:18.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":851,"price":192.44,"value":163766.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":6850,"source":{"system":"sec-edgar","filing":"0001225208-18-005498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818005498/doc4.xml","form_type":"4"}},{"id":4012923,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":31700,"kind":"person","name":"Palmer Eric P","position":1,"cik":"0001710190","reported_name":"Palmer Eric P","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-03-06T18:41:18.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":2701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2015-2017 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":7701,"source":{"system":"sec-edgar","filing":"0001225208-18-005498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818005498/doc4.xml","form_type":"4"}}],"next_cursor":"2018-03-06T18:41:18.000000Z,4012923"}